The Technical AnalystExchange: ASX Industry: Health Care Equipment & Services
Nanosonics Ltd Price, Forecast, Insider, Ratings, Fundamentals & Signals
-3.52% $2.74
America/New_York / 3 mai 2024 @ 02:10
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 830.16 mill |
| EPS: | 0.0500 |
| P/E: | 54.80 |
| Earnings Date: | Jul 31, 2024 |
| SharesOutstanding: | 302.98 mill |
| Avg Daily Volume: | 1.347 mill |
| RATING 2024-05-03 |
|---|
| A+ |
| Strong Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Buy | |
| Return On Asset: | Strong Buy | |
| DE: | Neutral | |
| P/E: | Strong Buy | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/21 | 4/21 | 2/22 | 4/22 | 2/23 | 4/23 | |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Gr.Profit | n/a | n/a | n/a | n/a | n/a | n/a |
| Ebit | n/a | n/a | n/a | n/a | n/a | n/a |
| Asset | n/a | n/a | n/a | n/a | n/a | n/a |
| Debt | n/a | n/a | n/a | n/a | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 43.57x |
| Company: PE 54.80 | sector: PE 1.258 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 1.01x |
| Company: PE 54.80 | industry: PE 54.21 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$1.436 (-47.58%) $-1.304 |
| Date: 2024-05-03 |
| Expected Trading Range (DAY) |
|---|
|
$ 2.65 - 2.87 ( +/- 3.84%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $2.74 (-3.52% ) |
| Volume | 0.500 mill |
| Avg. Vol. | 1.347 mill |
| % of Avg. Vol | 37.14 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For NAN.AX
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
NAN.AX
Nanosonics Limited, together with its subsidiaries, operates as an infection prevention company in Australia and internationally. The company engages in the manufacturing and distribution of the trophon ultrasound probe disinfector, and its associated consumables and accessories; and research, development, and commercialization of infection control and decontamination products and related technologies. It provides trophon2, an ultrasound probe high level disinfection device; trophon EPR, a low temperature high level disinfection solution for intra-cavity ultrasound probes; and Nanosonics AuditPro, an infection control workflow compliance management solution. Nanosonics Limited was incorporated in 2000 and is headquartered in Macquarie Park, Australia.